RIO DE JANEIRO, BRAZIL - During a press conference on Wednesday, December 23rd, the Butantan Institute and the government of São Paulo announced that the first results of the CoronaVac's safety and efficacy phase 3 trials had arrived. CoronaVac is a . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here